ACEI/ARB underused in patients with type 2 diabetes in Chinese population (CCMR-3B study).

ACEI/ARB underused in patients with type 2 diabetes in Chinese population (CCMR-3B study).

OBJECTIVE:In patients with diabetic kidney disease, it is well documented that RAS blockade is associated with an improved outcome. This observational, multicenter study examined the "real-world" use of ACEI/ARB in patients with type 2 diabetes (T2DM) in China. METHOD:Data from the China C...

Full description

Bibliographic Details
Main Authors: Qionghong Xie, Chuan-Ming Hao, Linong Ji, Dayi Hu, Tongying Zhu, Xuehai Li, Dandan Qin, Danyi Zhang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4326276?pdf=render

Internet

http://europepmc.org/articles/PMC4326276?pdf=render

Similar Items